نتایج جستجو برای: pharmacogenomic

تعداد نتایج: 2060  

Journal: :Journal of the American College of Cardiology 2018

2014
Jasmine A Talameh Joseph P Kitzmiller

Statins are the most commonly prescribed drugs in the United States and are extremely effective in reducing major cardiovascular events in the millions of Americans with hyperlipidemia. However, many patients (up to 25%) cannot tolerate or discontinue statin therapy due to statin-induced myopathy (SIM). Patients will continue to experience SIM at unacceptably high rates or experience unnecessar...

2016
Timothy Ramsey Elizabeth Griffin Qian Liu Mark D Brennan

Introduction: In clinical trials, pharmacogenetic testing has been shown to improve outcomes in psychiatric patients. It is unclear if these improved outcomes translate into routine clinical practice. A significant impediment to evaluation of pharmacogenetics testing in routine practice has been a lack of quantifiable outcomes data. This study leverages longitudinal symptom evaluations using va...

Journal: :Clinical genetics 2012
S B Haga J M O'Daniel G M Tindall R Mills I M Lipkus R Agans

Pharmacogenetic (PGx) testing aims to improve therapeutic outcomes through tailoring treatment based on a patient's genetic risk for non-response and/or an adverse event. Given their expertise, geneticists could facilitate the use of PGx testing; however, the preparedness and perceived role of the clinical genetics community is unclear. To assess the attitudes, preparedness, and perceived roles...

2017
Sollip Kim Yeo-Min Yun Hyo-Jin Chae Hyun-Jung Cho Misuk Ji In-Suk Kim Kyung-A Wee Woochang Lee Sang Hoon Song Hye In Woo Soo-Youn Lee Sail Chun

Pharmacogenetic testing for clinical applications is steadily increasing. Correct and adequate use of pharmacogenetic tests is important to reduce unnecessary medical costs and adverse patient outcomes. This document contains recommended pharmacogenetic testing guidelines for clinical application, interpretation, and result reporting through a literature review and evidence-based expert opinion...

Journal: :American family physician 2008
Donna J Belle Harleen Singh

Patients vary widely in their response to drugs. Having an understanding of the pharmacokinetic and pharmacodynamic properties of various medications is importantwhen assessing ethnic differences in drug response. Genetic factors can account for 20 to 95 percent of patient variability. Genetic polymorphisms for many drug-metabolizing enzymes and drug targets (e.g., receptors) have been identifi...

Journal: :Journal of the American Pharmacists Association : JAPhA 2012
Shanna K O'Connor Stefanie P Ferreri Natasha M Michaels Rebecca W Chater Anthony J Viera Hawazin Faruki Howard L McLeod Mary Roederer

OBJECTIVE To provide information for community pharmacies considering implementation of a pharmacogenetic testing service. SETTING A single community pharmacy from a regional chain. PRACTICE DESCRIPTION Community pharmacists at the study site routinely provide pharmacy services including medication therapy management, immunizations, point-of-care testing, blood pressure monitoring, and diab...

Journal: :Clinical pharmacology and therapeutics 2008
J J Swen I Wilting A L de Goede L Grandia H Mulder D J Touw A de Boer J M H Conemans T C G Egberts O H Klungel R Koopmans J van der Weide B Wilffert H-J Guchelaar V H M Deneer

Despite initial enthusiasm, the use of pharmacogenetics has remained limited to investigation in only a few clinical fields such as oncology and psychiatry. The main reason is the paucity of scientific evidence to show that pharmacogenetic testing leads to improved clinical outcomes. Moreover, for most pharmacogenetic tests (such as tests for genetic variants of cytochrome P450 enzymes) a detai...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید